NL7016922A - - Google Patents

Info

Publication number
NL7016922A
NL7016922A NL7016922A NL7016922A NL7016922A NL 7016922 A NL7016922 A NL 7016922A NL 7016922 A NL7016922 A NL 7016922A NL 7016922 A NL7016922 A NL 7016922A NL 7016922 A NL7016922 A NL 7016922A
Authority
NL
Netherlands
Application number
NL7016922A
Inventor
K Gerzon
H W Murphy
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NL7016922A publication Critical patent/NL7016922A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
NL7016922A 1969-11-21 1970-11-19 NL7016922A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87893669A 1969-11-21 1969-11-21

Publications (1)

Publication Number Publication Date
NL7016922A true NL7016922A (xx) 1971-05-25

Family

ID=25373117

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7016922A NL7016922A (xx) 1969-11-21 1970-11-19

Country Status (12)

Country Link
US (1) US3772270A (xx)
AT (1) AT300196B (xx)
BE (1) BE759252A (xx)
CA (1) CA936155A (xx)
CH (1) CH550164A (xx)
DE (1) DE2057188C3 (xx)
FR (1) FR2073400B1 (xx)
GB (1) GB1307100A (xx)
IE (1) IE34739B1 (xx)
IL (1) IL35606A (xx)
NL (1) NL7016922A (xx)
SE (1) SE375777B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5929219A (en) 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
US20040022740A1 (en) * 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100504A (en) * 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
ZA695765B (en) * 1968-08-29 1971-03-31 Lilly Co Eli Erythromycylamine and process for preparing same

Also Published As

Publication number Publication date
DE2057188A1 (de) 1971-06-03
FR2073400A1 (xx) 1971-10-01
FR2073400B1 (xx) 1974-08-30
IE34739L (en) 1971-05-21
SE375777B (xx) 1975-04-28
GB1307100A (en) 1973-02-14
CA936155A (en) 1973-10-30
DE2057188C3 (de) 1974-05-22
IL35606A0 (en) 1971-01-28
IL35606A (en) 1973-06-29
AT300196B (de) 1972-07-10
BE759252A (fr) 1971-05-21
DE2057188B2 (de) 1973-10-11
US3772270A (en) 1973-11-13
CH550164A (de) 1974-06-14
IE34739B1 (en) 1975-08-06

Similar Documents

Publication Publication Date Title
AU2270770A (xx)
AU465452B2 (xx)
AU429630B2 (xx)
AU450150B2 (xx)
AU2355770A (xx)
FR2073400A1 (xx)
AU442375B2 (xx)
AU427401B2 (xx)
AU470301B1 (xx)
AU442380B2 (xx)
AU442554B2 (xx)
AU428129B2 (xx)
AU428131B2 (xx)
AU425297B2 (xx)
AU428074B2 (xx)
AU438128B2 (xx)
AU470661B1 (xx)
AU442285B2 (xx)
AU442322B2 (xx)
AU442357B2 (xx)
AU410358B2 (xx)
AU414607B2 (xx)
AU442535B2 (xx)
AU442538B2 (xx)
AU5228269A (xx)